Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
| Country | United States |
|---|---|
| Deadline | 2027-08-18 (269 days left) |
| Published | 2024-10-01 |
| Sectors | Health & life sciences |
| Source | Grants.gov (US) |
Summary
Funding opportunity PAR-24-293. CFDA: 93.121, 93.867, 93.279, 93.242, 93.113, 93.853, 93.273, 93.213, 93.866
The buyer, the value, the full description and the link to the official notice are available with a free account.